pyrimidine has been researched along with Carcinoma, Pancreatic Ductal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoreo, CA; Bristow, CA; Buglioni, S; Cardone, L; Carrella, D; Carugo, A; Ciliberto, G; Del Bufalo, D; Di Bernardo, D; Draetta, GF; Fleming, JB; Huang, JK; Iezzi, M; Iuliano, A; Kang, Y; Kim, MP; Lamolinara, A; Manni, I; Melisi, D; Minelli, R; Mottini, C; Robinson, FS; Tomihara, H; Trisciuoglio, D | 1 |
| Beytagh, MC; Bhutkar, A; Colón, CI; Drapkin, BJ; Dyson, NJ; Farago, AF; Hsu, PP; Jacks, T; Lewis, CA; Li, L; Li, Z; Mercer, KL; Muzumdar, MD; Myers, DT; Nabel, CS; Ng, SR; Phat, S; Romero, R; Vander Heiden, MG; Westcott, PMK | 1 |
| Asara, JM; Bronson, RT; Kimmelman, AC; Lyssiotis, CA; Mashadova, O; Roeth, AA; Santana-Codina, N; Wang, X; Yang, A; Ying, H; Zhang, Y | 1 |
3 other study(ies) available for pyrimidine and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Decitabine; Drug Repositioning; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction | 2019 |
Identification of DHODH as a therapeutic target in small cell lung cancer.
Topics: Adenocarcinoma; Animals; Biphenyl Compounds; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; DCMP Deaminase; Dihydroorotate Dehydrogenase; Disease Progression; Enzyme Inhibitors; Humans; Lung Neoplasms; Mice; Molecular Targeted Therapy; Oxidoreductases Acting on CH-CH Group Donors; Pancreatic Neoplasms; Pyrimidines; Small Cell Lung Carcinoma; Survival Analysis; Xenograft Model Antitumor Assays | 2019 |
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis.
Topics: Animals; Carcinoma, Pancreatic Ductal; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Pancreatic Neoplasms; Pentose Phosphate Pathway; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrimidines | 2018 |